These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 277127)

  • 1. Drug metabolism in man: in vivo and in vitro correlations.
    Sotaniemi EA; Pelkonen RO; Ahokas J; Ahlqvist J; Hokkanen OT
    Arch Toxicol Suppl; 1978; (1):339-42. PubMed ID: 277127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug metabolism in epileptics: in vivo and in vitro correlations.
    Sotaniemi EA; Pelkonen RO; Ahokas J; Pirttiaho HI; Ahlqvist J
    Br J Clin Pharmacol; 1978 Jan; 5(1):71-6. PubMed ID: 619937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver size and indices of drug metabolism in alcoholics.
    Pirttiaho HI; Sotaniemi EA; Ahlqvist J; Pitkänen U; Pelkonen RO
    Eur J Clin Pharmacol; 1978 Mar; 13(1):61-7. PubMed ID: 639835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver size and indices of drug metabolism in epileptics.
    Pirttiaho HI; Sotaniemi EA; Ahokas JT; Pitkänen U
    Br J Clin Pharmacol; 1978 Sep; 6(3):273-8. PubMed ID: 687506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological changes in the liver and indices of drug metabolism in alcoholics.
    Sotaniemi EA; Ahlqvist J; Pelkonen RO; Pirttiaho H; Luoma PV
    Eur J Clin Pharmacol; 1977 Apr; 11(4):295-303. PubMed ID: 862651
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum zinc and serum copper and indices of drug metabolism in alcoholics.
    Hartoma TR; Sotaniemi EA; Pelkonen O; Ahlqvist J
    Eur J Clin Pharmacol; 1977 Oct; 12(2):147-51. PubMed ID: 923628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of the drug-metabolizing capacity in patients with diabetes mellitus.
    Salmela PI; Sotaniemi EA; Pelkonen RO
    Diabetes; 1980 Oct; 29(10):788-94. PubMed ID: 7439538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver size in evaluating drug metabolizing capacity in man.
    Pirttiaho H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):271-6. PubMed ID: 468452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between lipid composition and drug metabolizing capacity of human liver.
    Savolainen MJ; Arranto AJ; Hassinen IE; Luoma PV; Pelkonen RO; Sotaniemi EA
    Eur J Clin Pharmacol; 1985; 27(6):727-32. PubMed ID: 3987778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
    Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
    Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes.
    Farrell GC; Cooksley WG; Powell LW
    Clin Pharmacol Ther; 1979 Oct; 26(4):483-92. PubMed ID: 487696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of hepatic drug metabolism in patients with acute viral hepatitis.
    Narang AP; Datta DV; Nath N; Mathur VS
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):255-8. PubMed ID: 7166177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants.
    Pirttiaho HI; Sotaniemi EA; Pelkonen RO; Pitkänen U
    Eur J Clin Pharmacol; 1982; 22(5):441-5. PubMed ID: 7117357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays.
    Sotaniemi EA; Pelkonen RO; Puukka M
    Eur J Clin Pharmacol; 1980 Apr; 17(4):267-74. PubMed ID: 6105079
    [No Abstract]   [Full Text] [Related]  

  • 15. The suppressive effects of lipopolysaccharide-induced acute phase response on hepatic cytochrome P450-dependent drug metabolism in rabbits.
    Saitoh T; Kokue E; Shimoda M
    J Vet Pharmacol Ther; 1999 Apr; 22(2):87-95. PubMed ID: 10372593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug metabolism in diabetic subjects with fatty livers.
    Pirttiaho HI; Salmela PI; Sotaniemi EA; Pelkonen RO; Pitkänen U; Luoma PV
    Br J Clin Pharmacol; 1984 Dec; 18(6):895-9. PubMed ID: 6529530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of drugs and carcinogens in man: antipyrine elimination as an indicator.
    Kalamegham R; Krishnaswamy K; Krishnamurthy S; Bhargava RN
    Clin Pharmacol Ther; 1979 Jan; 25(1):67-73. PubMed ID: 31258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.
    Sotaniemi EA; Anttila M; Pelkonen RO; Järvensivu P; Sundquist H
    Clin Pharmacol Ther; 1979 Aug; 26(2):153-61. PubMed ID: 455885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic injury and drug metabolism in patients with alpha-methyldopa-induced liver damage.
    Sotaniemi EA; Hokkanen OT; Ahokas JT; Pelkonen RO; Ahlqvist J
    Eur J Clin Pharmacol; 1977 Dec; 12(6):429-35. PubMed ID: 598417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.